Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kaletra”

209 trials

Showing 20 of 209 results

Testing effectiveness (Phase 2)Study completedNCT00654147
What this trial is testing

Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects

Who this might be right for
HIV Infections
Margaret A. Fischl, M.D. 44
Testing effectiveness (Phase 2)Study completedNCT00109590
What this trial is testing

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 175
Testing effectiveness (Phase 2)Study completedNCT00052117
What this trial is testing

Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens

Who this might be right for
HIV Infections
Pfizer 300
Early research (Phase 1)Study completedNCT00038480
What this trial is testing

Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 31
Post-approval studies (Phase 4)Study completedNCT01581853
What this trial is testing

Pilot Simplification Study to Lopinavir/Ritonavir 800/200 mg Monotherapy Regimen Once Daily

Who this might be right for
HIV
Daniel Podzamczer 21
Not applicableStudy completedNCT01074931
What this trial is testing

Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China

Who this might be right for
HIV-1 Infections
Abbott 98
Early research (Phase 1)Study completedNCT00774735
What this trial is testing

GSK1349572 Drug Interaction Study With Protease Inhibitors

Who this might be right for
Healthy SubjectsInfection, Human Immunodeficiency Virus
GlaxoSmithKline 30
Not applicableStudy completedNCT00720590
What this trial is testing

Effect of the HIV Protease Inhibitors Atazanavir and Lopinavir/Ritonavir on Cardiovascular Disease Risk Factors

Who this might be right for
Endothelial Dysfunction
Indiana University 30
Not applicableStudy completedNCT00846599
What this trial is testing

Postprandial Endothelial Dysfunction After a High-Fat Meal in HIV-infected Men

Who this might be right for
HIV InfectionCardiovascular RiskHIV Infections
Tufts University 50
Large-scale testing (Phase 3)WithdrawnNCT01255371
What this trial is testing

A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir

Who this might be right for
HIV
ANRS, Emerging Infectious Diseases
Post-approval studies (Phase 4)UnknownNCT01453933
What this trial is testing

RAltegravir Switch STudy: Effects on Endothelial Recovery

Who this might be right for
HIV InfectionEndothelial Dysfunction
UMC Utrecht 24
Post-approval studies (Phase 4)Ended earlyNCT00414284
What this trial is testing

BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)

Who this might be right for
HIV Infections
Community Research Initiative of New England
Testing effectiveness (Phase 2)Study completedNCT00184951
What this trial is testing

Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients

Who this might be right for
HIV InfectionsHyperlipidemia
Radboud University Medical Center 30
Large-scale testing (Phase 3)Study completedNCT02671383
What this trial is testing

Evaluation of Low-dose Darunavir in a Switch Study

Who this might be right for
HIV Infections
Willem Daniel Francois Venter 300
Early research (Phase 1)Study completedNCT00076414
What this trial is testing

The Effect of Lopinavir/Ritonavir on Endothelial Function

Who this might be right for
Healthy
National Institutes of Health Clinical Center (CC) 30
Post-approval studies (Phase 4)UnknownNCT04350671
What this trial is testing

Interferon Beta 1a in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 40
Post-approval studies (Phase 4)Study completedNCT01045369
What this trial is testing

A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects

Who this might be right for
HIV Infections
Therapeutic Concepts 30
Not applicableStudy completedNCT01083173
What this trial is testing

Surveillance of Kaletra in Korean Patients

Who this might be right for
HIV-1 Infection
AbbVie (prior sponsor, Abbott) 595
Large-scale testing (Phase 3)WithdrawnNCT00476983
What this trial is testing

Pharmacokinetic and Efficacy of SQV/r 1500/100 Plus Tenofovir/Emtricitabine 300/200 mg

Who this might be right for
Saquinavir/Ritonavir BID or Lopinavir/Ritonavir BID
The HIV Netherlands Australia Thailand Research Collaboration
Large-scale testing (Phase 3)Study completedNCT00043966
What this trial is testing

Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects

Who this might be right for
HIV Infections
Abbott 200
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation